Baroni M G, Giorgino F, Pezzino V, Scaroni C, Avogaro A
Endocrinology and Diabetes, Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, Department of Emergency and Organ Transplantation, University of Bari Aldo Moro, Bari, Italy.
J Endocrinol Invest. 2016 Feb;39(2):235-55. doi: 10.1007/s40618-015-0404-6. Epub 2015 Dec 30.
Hyperglycemia is a common feature associated with states of increased growth hormone secretion and glucocorticoid levels. The purpose of these guidelines is to assist clinicians and other health care providers to take evidence-based therapeutic decisions for the treatment of hyperglycemia in patients with growth hormone and corticosteroid excess. Both the SID and SIE appointed members to represent each society and to collaborate in Guidelines writing. Members were chosen for their specific knowledge in the field. Each member agreed to produce-and regularly update-conflicts of interest. The authors of these guidelines prepared their contributions following the recommendations for the development of Guidelines, using the standard classes of recommendation shown below. All members of the writing committee provided editing and systematic review of each part of the manuscript, and discussed the grading of evidence. Consensus was guided by a systematic review of all available trials and by interactive discussions.
高血糖是与生长激素分泌增加和糖皮质激素水平升高状态相关的常见特征。这些指南的目的是协助临床医生和其他医疗保健提供者，针对生长激素和皮质类固醇过多患者的高血糖治疗做出基于证据的治疗决策。SID和SIE均指定成员代表各自学会并合作撰写指南。成员因其在该领域的专业知识而被选中。每位成员都同意披露并定期更新利益冲突情况。这些指南的作者按照指南制定的建议撰写文稿，并采用以下所示的标准推荐类别。撰写委员会的所有成员对手稿的每个部分进行编辑和系统审查，并讨论证据分级。通过对所有可用试验的系统评价和互动讨论达成共识。
